The estate of Henrietta Lacks can proceed with a lawsuit against Ultragenyx Pharmaceutical over the use of HeLa cells taken without her consent in the 1950s. A Maryland federal court ruled against Ultragenyx's motion to dismiss, allowing the case to continue.

RARE

Analyst Ratings

In-Depth Examination Of 4 Analyst Recommendations For Criteo

By Benzinga Insights

January 9, 9:00 AM

Criteo (NASDAQ:CRTO) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish…

CRTO

Marcus & Millichap Inc Announces Sale Of Fairfield Inn & Suites In Salem; No Financial Terms Disclosed

By Benzinga Newsdesk

October 19, 1:29 PM

https://www.marcusmillichap.com/news-events/press/2023/10/10-19-fairfield-inn-salemMarcus & Millichap (NYSE:MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research

MMI

Keybanc Maintains Overweight on Repligen, Raises Price Target to $260

Related Posts

Fed’s Evans Says If Inflation Reports Aren’t Favorable And Fed Still Wants To Hike Expeditiously, ‘you Can Do 50BP, Repeatedly’; Likely That Peak Federal Funds Rate In Central Bank’s Projections In December Will Be ‘Slightly Higher’ Than In September

Ultragenyx Faces Lawsuit Over Alleged Unjust Use of Henrietta Lacks’ Cells

In-Depth Examination Of 4 Analyst Recommendations For Criteo

Marcus & Millichap Inc Announces Sale Of Fairfield Inn & Suites In Salem; No Financial Terms Disclosed